Explore the TYO:3671 financials. Find the Softmax financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial ...
Molecular Devices Corporation has announced the launch of SoftMax Pro 5 data acquisition and analysis software for its extensive line of microplate readers. The software is available in two editions: ...
P/E Ratio (w/o extraordinary items) 10.43 ...
Qualcomm nabs SoftMax's noise-reduction technology for use in next-generation devices, including mobile phones, Bluetooth headsets, VoIP phones, and notebooks Qualcomm made a clear statement about its ...
Molecular Devices announced the launch of the new SoftMax® Pro 7.1 GxP Software with complete validation tools which achieves full FDA 21 CFR Part 11 compliance in GMP/GLP labs. Built on its current, ...
Softmax Co., Ltd engages in the development, sale, implementation, and maintenance of medical information and corporate systems in Japan. The company offers web based electronic medical record system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results